Outsourcing in Clinical Trials (OCT) East Coast 2024
Discover effective strategies for outsourcing clinical trial operations to ensure trials run smoothly and within budget. Attend OCT East for a two day event filled with case studies, panel discussion and face to face networking opportunities around clinical operations, technology and innovation, and data management.
Stop by the Clario Booth and talk to our experts about what is new!
Session information:
Title: A holistic approach to Parkinson’s disease endpoint data collection: efficacy, safety and quality of life
Date: Tuesday, May 21, 2024
Time: 2:30 p.m. – 3:00 p.m. (Eastern US Time)
Stream B: Clinical Technology & Innovation
Abstract:
Join us for a comprehensive exploration into Parkinson’s disease (PD) endpoint data collection, as we delve into the core elements of efficacy, safety, and quality of life. This session will highlight how the integration of different endpoint modalities provides researchers with a clear advantage in their mission to advance innovative therapeutics for this largely unmet medical need. The endpoint modalities to be discussed include:
- Wearable digital endpoint solutions and their pivotal role in providing quantitative gait assessment for detection of disease progression
- eCOA solutions for assessing efficacy and quality of life, leveraging clinical rating scales, symptom diaries, and other patient-reported outcome measures
- Medical imaging modalities focused on accurately characterizing PD status biologically, paving the way for biomarker-guided drug development
- Cardiac monitoring in this unique population, collecting high-quality blood pressure and cardiac rhythm data to characterize PD-associated autonomic dysfunction
Speaker
Todd Rudo, M.D.
Chief Medical Officer at Clario
As Clario’s Chief Medical Officer, Dr. Todd Rudo provides medical and scientific leadership across the organization. Passionate about leveraging Clario’s scientific resources to support customer success, Dr. Rudo has focused efforts on developing expertise across a range of therapeutic areas. His team provides expert consulting to clients on scientific and regulatory strategy, and ensures Clario’s product portfolio is scientifically robust, generating high quality clinical trial endpoint data. Dr. Rudo has a particular interest in applying innovative technologies to improve the scientific rigor of clinical trials, while also maintaining focus on patient and site burden. With nearly 20 years of clinical cardiology and pharmaceutical research experience, Dr. Rudo has focused predominantly on drug safety, working across a wide range of therapeutic areas.
Meet with us at Outsourcing in Clinical Trials (OCT) East Coast 2024.
Complete this form and we will reach out soon to schedule a time to connect at the event.
If you are a company wishing to collaborate with us, please stop by our booth during the conference to talk with our team.